Showing results (61-70 of 130) with videos related to
Sort By:
Pageof 13
Transplantation|May 29, 1998
CD30 expression identifies a functional alloreactive human T-lymphocyte subsetO M Martinez, J Villanueva, S Abtahi, et al.Anticancer Research|November 1, 1996
T cell receptor usage by cytotoxic T lymphocytes against autologous human melanomaS P Leong, J Liliental, S M Krams, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2006
EBV can protect latently infected B cell lymphomas from death receptor-induced apoptosisAndrew L Snow, Stacie L Lambert, Yasodha Natkunam, et al.Cancer Research|August 9, 2003
Rapamycin inhibits the interleukin 10 signal transduction pathway and the growth of Epstein Barr virus B-cell lymphomasRonald R Nepomuceno, Cynthia E Balatoni, Yaso Natkunam, et al.Transplantation|May 1, 1993
IL-2 and IL-5 gene expression in response to alloantigen in liver allograft recipients and in vitroO M Martinez, J C Villanueva, J Lake, et al.Stem Cells (Dayton, Ohio)|June 5, 2013
Natural killer cell-activating receptor NKG2D mediates innate immune targeting of allogeneic neural progenitor cell graftsLori K Phillips, Elizabeth A Gould, Harish Babu, et al.Transplantation|February 27, 1995
Viral and immunologic aspects of Epstein-Barr virus infection in pediatric liver transplant recipientsO M Martinez, J C Villanueva, L Lawrence-Miyasaki, et al.Transplantation|February 27, 1995
Apoptosis as a mechanism of cell death in liver allograft rejectionS M Krams, H Egawa, M B Quinn, et al.The Clinical Investigator|December 1, 1994
Elevation of intracranial pressure in acute AIDS-related cryptococcal meningitisR Malessa, M Krams, U Hengge, et al.Transplantation|April 1, 1993
Evidence for a nonclassical pathway of graft rejection involving interleukin 5 and eosinophilsO M Martinez, N L Ascher, L Ferrell, et al.Pageof 13